$BCYC· SEC filing ·

BCYC Reports $628M Cash, $65M Q4 Rev, +15% YoY, Announces Workforce Cut 30%, Focuses on BT5528, Duravelo-2 Converted to Phase 2, Cash Runway to 2030

Bicycle Therapeutics plc American Depositary Shares · PHARMACEUTICAL PREPARATIONS · Now $4.53

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS